We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Design of an Oral Tablet Containing Furosemide Nanoparticles with Elevated Bioavailability.
- Authors
Noriaki Nagai; Fumihiko Ogata; Reita Kadowaki; Saori Deguchi; Hiroko Otake; Yosuke Nakazawa; Misra, Manju; Naohito Kawasaki
- Abstract
The solubility and permeability of the Biopharmaceutics Classification System (BCS) class IV drugs, such as furosemide (FUR), are low. Thus, the oral bioavailability of these drugs needs to be augmented. Here, we aimed to design orally disintegrating tablets containing FUR nanoparticles to improve bioavailability after oral administration. The FUR nanoparticles were generated by bead-milling in water containing 0.5% methylcellulose and 0.5% 2-hydroxypropyl-β-cyclodextrin (w/w%). Particle size was approximately 47–350 nm (mean particle size, 188 nm). An orally disintegrating tablet (FUR-NP tablet) comprising FUR nanoparticles (1%) was successfully produced by employing suspensions outlined above that incorporated additives (4% D-mannitol, 0.4% polyvinylpyrrolidone, and 16% gum Arabic, w/w%), followed by freeze-drying. The FUR-NP tablet disaggregated after only 5 s in water, liberating nano-sized FUR particles (172 nm). Experiments using rats showed the absorption of the FUR-NP tablet was significantly improved by comparison with a FUR tablet containing microparticles. In summary, the orally disintegrating tablet containing FUR nanoparticles markedly enhanced the bioavailability of FUR. We anticipate this formulation will also improve the bioavailability of other BCS class IV drugs.
- Subjects
ORAL drug administration; NANOPARTICLES; BIOAVAILABILITY; FUROSEMIDE; DRUG bioavailability; FREEZE-drying; DRUG solubility
- Publication
Journal of Oleo Science, 2024, Vol 73, Issue 4, p563
- ISSN
1345-8957
- Publication type
Article
- DOI
10.5650/jos.ess23229